首页 > 市场调查报告书 > 製药

消化器

市场调查报告书

商品编码

1532645

胃肠道诊断市场 - 按测试类型、技术、应用、最终用途和全球预测

Gastrointestinal Diagnostics Market - By Test Type, Technology, Application, End-use & Global Forecast

出版日期: 2024年05月31日 | 出版商:

Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在创新设备推出激增的推动下，2024 年至 2032 年间，全球胃肠道诊断市场复合年增长率将达到 4.6a%。诊断技术的最新进展正在提高胃肠道评估的准确性、速度和舒适度。新设备，如先进的内视镜、胶囊内视镜和非侵入性影像工具，提供了改进的可视化和诊断功能，能够更早、更精确地检测胃肠道疾病。

这些创新对于治疗大肠直肠癌、克隆氏症和肠躁症等复杂疾病至关重要。例如，2024 年 5 月，诊断和治疗医疗技术领域的领先公司 Laborie Medical Technologies Corp. 推出了太阳能紧凑型系统和太阳能肛门直肠测压导管，这是首款一次性 HRAM 导管。

人们对胃肠道健康意识的增强和对个人化医疗的需求也推动了创新诊断工具的兴起。提高诊断准确性有助于制定治疗计划、改善患者治疗效果并降低医疗成本。随着製造商不断开发和推出尖端设备，在对先进、高效和患者友好的诊断解决方案的需求的推动下，胃肠道诊断市场预计将进一步扩大。

胃肠道诊断行业的整体价值根据测试类型、技术、应用、最终用途和地区进行分类。

根据测试类型，血液检测领域的胃肠道诊断市场收入从2024 年到2032 年将实现令人称道的复合年增长率。提供非侵入性、准确的方法。这些测试利用生物标记和遗传指标来提供早期诊断和监测疾病进展。血液检测的便利性和减少的患者不适感推动了血液检测的日益普及。此外，对预防性医疗保健和早期检测的重视正在推动市场扩张。随着研究不断提高血液检测的功效和范围，其在胃肠道诊断中的作用预计将进一步提振市场需求。

在技术方面，ELISA 领域将在2024 年至2032 年出现显着增长。和癌症）相关的生物标记。它提供准确定量结果的能力使其在临床和研究环境中具有无价的价值。胃肠道疾病的盛行率不断增加以及对可靠诊断工具的需求正在推动对基于 ELISA 的检测的需求。随着技术的进步和更多生物标记的发现，ELISA 在胃肠道诊断中的作用预计将扩大，进一步推动市场成长。

欧洲胃肠道诊断市场从2024年到2032年将呈现显着的复合年增长率。，以提高胃肠道疾病检测和管理的准确性和效率。该地区对早期诊断和个人化医疗的关注进一步刺激了需求。此外，严格的监管标准和研发投资支持创新诊断解决方案的成长。随着欧洲继续优先考虑胃肠道健康和先进诊断，预计该市场将持续强劲成长。

产业生态系统分析
产业影响力
- 成长动力
  - 胃肠道疾病盛行率增加
  - 越来越多地采用非侵入性测试
  - 人们对胃肠道健康的认识不断提高
  - 诊断技术的技术进步
- 产业陷阱与挑战
  - 诊断程序成本高
  - 有限的报销政策
成长潜力分析
监管环境
技术景观
波特的分析
PESTEL分析
未来市场趋势

第 4 章：竞争格局

介绍
公司市占率分析
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按测试类型，2021 - 2032 年

主要趋势
内视镜检查
验血
免疫球蛋白A测试
幽门螺旋桿菌检测
钙卫蛋白测试
其他测试类型

第 6 章：市场估计与预测：按技术分类，2021 - 2032 年

主要趋势
培养和敏感度测试
酵素连结免疫吸附试验
聚合酶炼式反应
影像技术
快速诊断测试
其他技术

第 7 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
感染
胃肠癌
发炎性肠道疾病
胃食道逆流症（GERD）
其他应用

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
医院
诊断实验室
其他最终用户

第 9 章：市场估计与预测：按地区划分，2021 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 10 章：公司简介

Abbott Laboratories
Beckman Coulter, Inc.
Becton, Dickinson and Company
bioMerieux
Bio-Rad Laboratories, Inc.
DiaSorin S.p.A
EKF Diagnostics Holdings plc
F. Hoffmann-La Roche Ltd
Fujifilm Holdings Corporation
Meridian Bioscience
QIAGEN N.V.
R-Biopharm AG
Siemens Healthineers AG
Sysmex Corporation
Thermo Fisher Scientific Inc.

简介目录

Product Code: 9711

Global Gastrointestinal Diagnostics Market will witness 4.6a% CAGR between 2024 and 2032, driven by the surge in innovative device launches. Recent advancements in diagnostic technology are enhancing the accuracy, speed, and comfort of gastrointestinal assessments. New devices, such as advanced endoscopes, capsule endoscopes, and non-invasive imaging tools, offer improved visualization and diagnostic capabilities, enabling earlier and more precise detection of gastrointestinal conditions.

These innovations are crucial for managing complex disorders like colorectal cancer, Crohn's disease, and irritable bowel syndrome. For instance, in May 2024, Laborie Medical Technologies Corp., a leading company in diagnostic and therapeutic medical technology, launched the Solar Compact System and the Solar Anorectal Manometry Catheter, which first disposable HRAM catheter available.

The rise in innovative diagnostic tools is also fueled by increasing awareness of gastrointestinal health and the demand for personalized medicine. Enhanced diagnostic accuracy helps in tailoring treatment plans, improving patient outcomes, and reducing healthcare costs. As manufacturers continue to develop and introduce cutting-edge devices, the gastrointestinal diagnostics market is expected to expand further, driven by the need for advanced, efficient, and patient-friendly diagnostic solutions.

The overall Gastrointestinal Diagnostics Industry value is classified based on the test type, technology, application, end-use, and region.

Based on test type, the gastrointestinal diagnostics market revenue from the blood test segment will register a commendable CAGR from 2024 to 2032. Innovative blood-based diagnostic assays are offering non-invasive, accurate methods for detecting gastrointestinal disorders, such as colorectal cancer and inflammatory bowel disease. These tests utilize biomarkers and genetic indicators to provide early diagnosis and monitor disease progression. The convenience and reduced patient discomfort associated with blood tests drive their growing popularity. Additionally, the emphasis on preventive healthcare and early detection is fueling market expansion. As research continues to enhance the efficacy and range of blood tests, their role in gastrointestinal diagnostics is expected to further boost market demand.

In terms of technology, the ELISA segment will witness an appreciable growth from 2024 to 2032. ELISA offers a highly sensitive and specific method for detecting biomarkers related to various gastrointestinal conditions, including infections, inflammatory diseases, and cancers. Its ability to provide accurate quantitative results makes it invaluable in both clinical and research settings. The increasing prevalence of gastrointestinal disorders and the need for reliable diagnostic tools are driving the demand for ELISA-based tests. As technology advances and more biomarkers are identified, the role of ELISA in gastrointestinal diagnostics is expected to expand, further fueling market growth.

Europe gastrointestinal diagnostics market will exhibit a notable CAGR from 2024 to 2032. European healthcare providers are increasingly adopting advanced diagnostic tools, such as endoscopes, imaging devices, and biomarker tests, to enhance the accuracy and efficiency of gastrointestinal disease detection and management. The region's focus on early diagnosis and personalized medicine further fuels demand. Additionally, stringent regulatory standards and investments in research and development support the growth of innovative diagnostic solutions. As Europe continues to prioritize gastrointestinal health and advanced diagnostics, the market is expected to see continued robust growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of gastrointestinal diseases
  - 3.2.1.2 Growing adoption of non-invasive tests
  - 3.2.1.3 Rising awareness about gastrointestinal health
  - 3.2.1.4 Technological advancements in diagnostic technologies
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of diagnostic procedures
  - 3.2.2.2 Limited reimbursement policies
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.7 PESTEL analysis
3.8 Future market trends

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Endoscopy
5.3 Blood test
5.4 Immunoglobulin A test
5.5 H. pylori test
5.6 Calprotectin test
5.7 Other test types

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Culture and sensitivity testing
6.3 ELISA
6.4 PCR
6.5 Imaging technologies
6.6 Rapid diagnostic tests
6.7 Other technologies

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Infection
7.3 Gastrointestinal cancer
7.4 Inflammatory bowel disease
7.5 Gastroesophageal reflux disease (GERD)
7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Diagnostic laboratories
8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa